Deep brain stimulation and cognitive decline in Parkinson's disease: A clinical review

Frontiers in Neurology

Volumn APR, Issue , 2012, Pages

  Massano, João ^a,b   Garrett, Carolina ^a,b  

^a Centro Hospitalar Universitário de São João   (Portugal)

^b University of Porto   (Portugal)

Author keywords

Cognitive impairment; Deep brain stimulation; Dementia; Functional impairment; Globus pallidus interna; Parkinson's disease; Quality of life; Subthalamic nucleus

Indexed keywords

EID: 84865994073     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2012.00066     Document Type: Article

References (115)

1. Aarsland, D., and Kurz, M. W. (2010). The epidemiology of dementia associated with Parkinson disease. J. Neurol. Sci. 289, 18-22.
2. Alegret, M., Junqué, C., Valldeori-ola, F., Vendrell, P., Pilleri, M., Rumià, J., and Tolosa, E. (2001). Effects of bilateral subthalamic stimulation on cognitive function in Parkinson disease. Arch. Neurol. 58, 1223-1227.
3. Anderson, V. C., Burchiel, K. J., Hogarth, P., Favre, J., and Hammerstad, J. P. (2005). Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease. Arch. Neurol. 62, 554-560.
4. Ardouin, C., Pillon, B., Peiffer, E., Bej-jani, P., Limousin, P., Damier, P., Arnulf, I., Benabid, A., Agid, Y., and Pollak, P. (1999). Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions: a consecutive series of 62 patients. Ann. Neurol. 46, 217-223.
5. Aybek, S., Gronchi-Perrin, A., Berney, A., Chiuvé, S. C., Villemure, J.-G., Burkhard, P. R., and Vinger-hoets, E J. G. (2007). Long-term cognitive profile and incidence of dementia after STN-DBS in Parkinson's disease. Mov. Disord. 22, 974-981.
6. Aybek, S., Lazeyras, F., Gronchi-Perrin, A., Burkhard, P. R., Villemure, J.-G., and Vingerhoets, E J. G. (2009). Hippocampal atrophy predicts conversion to dementia after STN-DBS in Parkinson's disease. Parkinsonism Relat. Disord. 15,521-524.
7. Ballard, C., Gauthier, S., Corbett, A., Brayne, C., Aarsland, D., and Jones, E. (2011). Alzheimer's disease. Lancet 377, 1019-1031.
8. Barone, P., Aarsland, D., Burn, D., Emre, M., Kulisevsky, J., and Weintraub, D. (2011). Cognitive impairment in nondemented Parkinson's disease. Mov. Disord. 26, 2483-2495.
9. Bell, E., Maxwell, B., McAndrews, M. P., Sadikot, A., and Racine, E. (2011). Deep brain stimulation and ethics: perspectives from a multi-site qualitative study of Canadian neurosurgical centers. World Neuro-surg. 76, 537-547.
10. Benabid, A. L., Pollak, P., Louveau, A., Henry, S., and de Rouge-mont, J. (1987). Combined (thalam-otomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease. Appl. Neurophysiol. 50, 344-346.
11. Broen, M., Duits, A., Visser-Vandewalle, V., Temel, Y., and Winogrodzka, A. (2011). Impulse control and related disorders in Parkinson's disease patients treated with bilateral subthalamic nucleus stimulation: a review. Parkinsonism Relat. Disord. 17,413-417.
12. Bronstein, J. M., Tagliati, M., Alterman, R. L., Lozano, A. M., Volkmann, J., Stefani, A., Horak, E B., Okun, M. S., Foote, K. D., Krack, P., Pahwa, R., Henderson, J. M., Hariz, M. I., Bakay, R.A.,Rezai,A.,Marks,W.J.Jr.,Moro, E., Vitek, J. L., Weaver, E M., Gross, R. E., and DeLong, M. R. (2011). Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues. Arch. Neurol. 68, 165-171.
13. Caparros-Lefebvre, D., Blond, S., Pecheux, N., Pasquier, F., and Petit, H. (1992). [Neuropsychological evaluation before and after thalamic stimulation in 9 patients with Parkinson disease]. Rev. Neurol. (Paris) 148,117-122.
14. Castelli, L., Lanotte, M., Zibetti, M., Caglio, M., Rizzi, L., Ducati, A., Bergamasco, B., and Lopiano, L. (2007). Apathy and verbal fluency in STN-stimulated PD patients. An observational follow-up study. J. Neurol. 254, 1238-1243.
15. Castelli, L., Perozzo, P., Zibetti, M., Crivelli, B., Morabito, U., Lanotte, M., Cossa, F., Bergamasco, B., and Lopiano, L. (2006). Chronic deep brain stimulation of the subthalamic nucleus for Parkinson's disease: effects on cognition, mood, anxiety and personality traits. Eur. Neurol. 55, 136-144.
16. Castrioto, A., Lozano, A. M., Poon, Y.-Y., Lang, A. E., Fallis, M., and Moro, E. (2011). Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation. Arch. Neurol. 68, 1550-1556.
17. Caviness, J. N., Driver-Dunckley, E., Connor, D. J., Sabbagh, M. N., Hentz, J. G., Noble, B., Evidente, V G. H., Shill, H. A., and Adler, C. H. (2007). Defining mild cognitive impairment in Parkinson's disease. Mov. Disord. 22, 1272-1277.
18. Chaudhuri, K. R., and Schapira, A. H. V (2009). Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment. Lancet Neurol. 8, 464-474.
19. Chou, K. L., Amick, M. M., Brandt, J., Camicioli, R., Frei, K., Gitelman, D., Goldman, J., Growdon, J., Hurtig, H. I., Levin, I., Litvan, I., Marsh, L., Simuni, T., Tröster, A. I., Uc, E. Y., and Parkinson Study Group Cognitive/Psychiatric Working Group. (2010). A recommended scale for cognitive screening in clinical trials of Parkinson's disease. Mov. Disord. 25,2501-2507.
20. Clausen, J. (2010). Ethical brain stimulation - neuroethics of deep brain stimulation in research and clinical practice. Eur. J. Neurosci. 32, 1152-1162.
21. Daniele, A., Albanese, A., Contarino, M. E, Zinzi, P., Barbier, A., Gasparini, F., Romito, L. M., Bentivoglio, A. R., and Scerrati, M. (2003). Cognitive and behavioural effects of chronic stimulation of the subthalamic nucleus in patients with Parkinson's disease. J. Neurol. Neurosurg. Psychiatr. 74, 175-182.
22. De Gaspari, D., Siri, C., Di Gioia, M., Antonini, A, Isella, V., Pizzolato, A, Landi, A, Vergani, F., Gaini, S. M., Appollonio, I. M., and Pezzoli, G. (2006). Clinical correlates and cognitive underpinnings of verbal fluency impairment after chronic subthalamic stimulation in Parkinson's disease. Parkinsonism Relat. Disord. 12,289-295
23. Defer, G. L., Widner, H., Marié, R. M., Rémy, P., and Levivier, M. (1999). Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD). Mov. Disord. 14, 572-584.
24. Denheyer, M., Kiss, Z. H., and Haffenden, A. M. (2009). Behavioral effects of subthalamic deep brain stimulation in Parkinson's disease. Neuropsychologia 47, 3203-3209.
25. Deuschl, G., Schade-Brittinger, C., Krack, P., Volkmann, J., Schäfer, H., Bötzel, K., Daniels, C., Deutschlän-der, A., Dillmann, U., Eisner, W., Gruber, D., Hamel, W., Herzog, J., Hilker, R., Klebe, S., Kloss, M., Koy, J., Krause, M., Kupsch, A., Lorenz, D., Lorenzl, S., Mehdorn, H. M., Moringlane, J. R., Oertel, W., Pinsker, M. O., Reichmann, H., Reuss, A., Schneider, G. H., Schnit-zler, A., Steude, U., Sturm, V., Tim-mermann, L., Tronnier, V., Trot-tenberg, T., Wojtecki, L., Wolf, E., Poewe, W., Voges, J., and German Parkinson Study Group, Neurostim-ulation Section. (2006). A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl. J. Med. 355, 896-908.
26. Djamshidian, A., Averbeck, B. B., Lees, A. J., and O'Sullivan, S. S. (2011). Clinical aspects of impulsive compulsive behaviours in Parkinson's disease. J. Neurol. Sci. 310, 183-188.
27. Domellöf, M. E., Elgh, E., and Fors-gren, L. (2011). The relation between cognition and motor dysfunction in drug-naive newly diagnosed patients with Parkinson's disease. Mov. Disord. 26,2183-2189.
28. Dorsey, E. R., Constantinescu, R., Thompson, J. P., Biglan, K. M., Hol-loway, R. G., Kieburtz, K., Marshall, E J., Ravina, B. M., Schi-fitto, G., Siderowf, A., and Tanner, C. M. (2007). Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 68, 384-386.
29. Emre, M., Aarsland, D., Brown, R., Burn, D. J., Duyckaerts, C., Mizuno, Y., Broe, G. A., Cummings, J., Dick-son, D. W., Gauthier, S., Goldman, J., Goetz, C., Korczyn, A., Lees, A., Levy, R., Litvan, I., McKeith, I., Olanow, W., Poewe, W., Quinn, N., Sam-paio, C., Tolosa, E., and Dubois, B. (2007). Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov. Disord. 22, 1689-1707.
30. Erola, T., Heikkinen, E. R., Haapaniemi, T., Tuominen, J., Juolasmaa, A., and Myllylä, V. V. (2006). Efficacy of bilateral subthalamic nucleus (STN) stimulation in Parkinson's disease. Acta Neurochir. (Wien) 148, 389-394.
31. Evans, A. H., Strafella, A. P., Weintraub, D., and Stacy, M. (2009). Impulsive and compulsive behaviors in Parkinson's disease. Mov. Disord. 24, 1561-1570.
32. Fasano, A., Romito, L. M., Daniele, A., Piano, C., Zinno, M., Bentivoglio, A. R., and Albanese, A. (2010). Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants. Brain 133, 2664-2676.
33. Follett, K., Weaver, F., and Stern, M. (2010). Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. N. Engl. J. Med. 362, 2077-2091.
34. Funahashi, S. (2001). Neuronal mechanisms of executive control by the prefrontal cortex. Neurosci. Res. 39, 147-165.
35. Funkiewiez, A., Ardouin, C., Caputo, E., Krack, P., Fraix, V., Klinger, H., Chabardes, S., Foote, K., Benabid, A.L., and Pollak, P. (2004). Long term effects of bilateral subthala mic nucleus stimulation on cog nitive function, mood, and behav iour in Parkinson's disease. J. Neurol. Neurosurg. Psychiatr. 75, 834-839.
36. Funkiewiez, A., Ardouin, C., Krack, P., Fraix, V., Van Blercom, N., Xie, J., Moro, E., Benabid, A.-L., and Pollak, P. (2003). Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease. Mov. Disord. 18, 524-530.
37. Gallagher, D. A., Lees, A. J., and Schrag,A. (2010).What are themost important nonmotor symptoms in patients with Parkinson's disease and are we missing them? Mov. Disord. 25,2493-2500.
38. Godefroy, O. (2003). Frontal syndrome and disorders of executive functions. J. Neurol. 250, 1-6.
39. Goetz, C. G., Emre, M., and Dubois, B. (2008). Parkinson's disease dementia: definitions, guidelines, and research perspectives in diagnosis. Ann. Neurol. 64, S81-S92.
40. Hälbig, T. D., Tse, W., Frisina, P. G., Baker, B. R., Hollander, E., Shapiro, H., Tagliati, M., Koller, W C, and Olanow, C. W (2009). Subthalamic deep brain stimulation and impulse control in Parkinson's disease. Eur. J. Neurol. 16,493-497.
41. Hariz, M. I., Rehncrona, S., Quinn, N. P., Speelman, J. D., and Wensing, C. (2008). Multicenter study on deep brain stimulation in Parkinson's disease: an independent assessment of reported adverse events at 4 years. Mov. Disord. 23,416-421.
42. Hawkes, C. H., Del Tredici, K., and Braak, H. (2010). A timeline for Parkinson's disease. Parkinsonism Relat. Disord. 16, 79-84.
43. Heo, J.-H., Lee, K.-M., Paek, S. H., Kim, M.-J., Lee, J.-Y., Kim, J.-Y., Cho, S.-Y., Lim, Y H., Kim, M.-R., Jeong, S. Y., and Jeon, B. S. (2008). The effects of bilateral subthalamic nucleus deep brain stimulation (STN DBS) on cognition in Parkinson disease. J. Neurol Sci. 273, 19-24.
44. Hershey, T., Revilla, F., Wernle, A., Gibson, P. S., Dowling, J., and Perlmutter, J. (2004). Stimulation of STN impairs aspects of cognitive control in PD. Neurology 62, 1110-1114.
45. Hoops, S., Nazem, S., Siderowf, A. D., Duda, J. E., Xie, S. X., Stern, M. B., and Weintraub, D. (2009). Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology 73, 1738-1745.
46. Jellinger, K. A., and Attems, J. (2008). Cerebral amyloid angiopathy in Lewy body disease. J. Neural Transm. 115,473-482.
47. Kaszás, B., Kovács, N., Balás, I., Kál-lai, J., Aschermann, Z., Kerekes, Z., Komoly, S., Nagy, F., Jan-szky, J., Lucza, T., and Karádi, K. (2012). Sensitivity and specificity of Addenbrooke's Cognitive Examination, Mattis Dementia Rating Scale, Frontal Assessment Battery and Mini Mental State Examination for diagnosing dementia in Parkinson's disease. Parkinsonism Relat. Disord. PMID: 22405839. [Epub ahead of print].
48. Kishore, A., Rao, R., Krishnan, S., Panikar, D., Sarma, G., Sivasana-karan, M. P., and Sarma, S. (2010). Long-term stability of effects of subthalamic stimulation in Parkinson's disease: Indian experience. Mov. Disord. 25,2438-2444.
49. Kleiner-Fisman, G., Herzog, J., Fisman, D. N., Tamma, F., Lyons, K. E., Pahwa, R., Lang, A. E., and Deuschl, G. (2006). Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov. Disord. 21(Suppl. 1),S290-S304.
50. Korczyn, A. D., and Vakhapova, V. (2007). The prevention of the dementia epidemic. J. Neurol. Sci. 257, 2-4.
51. Kovacs, G. G., Alafuzoff, I., Al-Sarraj, S., Arzberger, T., Bogdanovic, N., Capellari, S., Ferrer, I., Gelpi, E., Kövari, V., Kretzschmar, H., Nagy, Z., Parchi, P., Seilhean, D., Soininen, H., Troakes, C., and Budka, H. (2008). Mixed brain pathologies in dementia: the Brain-Net Europe consortium experience. Dement. Geriatr. Cogn. Disord. 26, 343-350.
52. Krack, P., Batir, A., Van Blercom, N., Chabardes, S., Fraix, V., Ardouin, C., Koudsie, A., Limousin, P. D., Benazzouz, A., LeBas, J. F., Benabid, A. L., and Pollak, P. (2003). Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Eng. J. Med. 349, 1925-1934.
53. Kulisevsky J., and Pagonabarraga, J. (2009). Cognitive impairment in Parkinson's disease: tools for diagnosis and assessment. Mov. Disord. 24, 1103-1110.
54. Lang, A. E. (2009). When and how should treatment be started in Parkinson disease? Neurology 72, S39-S43.
55. Lang, A. E., Houeto, J.-L., Krack, P., Kubu, C., Lyons, K. E., Moro, E., Ondo, W., Pahwa, R., Poewe, W., Tröster, A. I., Uitti, R., and Voon, V. (2006). Deep brain stimulation: preoperative issues. Mov. Disord. 21(Suppl. 1), S171-S196.
56. Lees, A. J., Hardy, J., and Revesz, T. (2009). Parkinson's disease. Lancet 373, 2055-2066.
57. Lim, S.-Y., Fox, S. H., and Lang, A. E. (2009). Overview of the extranigral aspects of Parkinson disease. Arch. Neurol. 66, 167-172.
58. Limousin, P., Krack, P., and Pollak, P. (1998). Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl. J. Med. 339,1105-1111.
59. Loher, T. J., Gutbrod, K., Fravi, N. L., Pohle, T., Burgunder, J.-M., and Krauss, J. K. (2003). Thalamic stimulation for tremor. Subtle changes in episodic memory are related to stimulation per se and not to a microthalamotomy effect. J. Neurol. 250,707-713.
60. Lopiano, L., Rizzone, M., Bergamasco, B., Tavella, A., Torre, E., Perozzo, P., Valentini, M., and Lanotte, M. (2001). Deep brain stimulation of the subthalamic nucleus: clinical effectiveness and safety. Neurology 56, 552-554.
61. Mallet, L., Schüpbach, M., N'Diaye, K., Remy, P., Bardinet, E., Czer-necki,V., Welter, M.-L., Pelissolo, A., Ruberg, M., Agid, Y., and Yelnik, J. (2007). Stimulation of sub territories of the subthalamic nucleus reveals its role in the integration of the emotional and motor aspects of behavior. Proc. Natl. Acad. Sci. U.S.A. 104, 10661-10666.
62. Massano, J., and Bhatia, K. P. (2012). Clinical approach to Parkinson's disease: features, diagnosis, and principles of management. Cold Spring Harb. Perspect. Med. doi:10.1101/cshperspect.000870
63. Mayeux, R. (2010). Clinical practice. Early Alzheimer's disease. N Engl. J. Med. 362,2194-2201.
64. McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., Mohs, R. C., Morris, J. C., Rossor, M. N., Schel-tens, P., Carrillo, M. C., Thies, B., Weintraub, S., and Phelps, C. H. (2011). The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 7,263-269.
65. Merola, A., Zibetti, M., Angrisano, S., Rizzi, L., Ricchi, V., Artusi, C. A., Lanotte, M., Rizzone, M. G., and Lopiano, L. (2011). Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients. Brain 134, 2074-2084.
66. Miller, B. L., and Cummings, J. L. (2007). The Human Frontal Lobes: Functions and Disorders, 2nd Edn. New York: The Guilf ord Press.
67. Moro, E., and Lang, A. E. (2006). Criteria for deep-brain stimulation in Parkinson's disease: review and analysis. Expert Rev. Neurother. 6, 1695-1705.
68. Moro, E., Lozano, A. M., Pollak, P., Agid, Y., Rehncrona, S., Volkmann, J., Kulisevsky, J., Obeso, J. A., Albanese, A., Hariz, M. I., Quinn, N. P., Speelman, J. D., Benabid, A. L., Fraix, V., Mendes, A., Welter, M. L., Houeto, J. L., Cornu, P., Dormont, D., Torn-qvist, A. L., Ekberg, R., Schnitzler, A., Timmermann, L., Wojtecki, L., Gironell, A., Rodriguez-Oroz, M. C., Guridi, J., Bentivoglio, A. R., Con-tarino, M. F., Romito, L., Scerrati, M., Janssens, M., and Lang, A. E. (2010). Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease. Mov. Disord. 25, 578-586.
69. Morrison, C. E., Borod, J. C., Perrine, K., Beric, A., Brin, M. F., Rezai, A., Kelly, P., Sterio, D., Germano, I., Weisz, D., and Olanow, C. W. (2004). Neuropsychological functioning following bilateral subthalamic nucleus stimulation in Parkinson's disease. Arch. Clin. Neuropsy-chol. 19,165-181.
70. Obeso, J. A., Marin, C., Rodriguez-Oroz, C., Blesa, J., Benitez-Temiño, B., Mena-Segovia, J., Rodríguez, M., and Olanow, C. W. (2008). The basal ganglia in Parkinson's disease: current concepts and unexplained observations. Ann. Neurol. 64(Suppl. 2), S30-S46.
71. Okun, M. S., Fernandez, H. H., Wu, S. S., Kirsch-Darrow, L., Bowers, D., Bova, F., Suelter, M., Jacobson, C. E., Wang, X., Gordon, C. W., Zeil-man, P., Romrell, J., Martin, P., Ward, H., Rodriguez, R. L., and Foote, K. D. (2009). Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE trial. Ann. Neurol. 65, 586-595.
72. Okun, M. S., Rodriguez, R. L., Mikos, A., Miller, K., Kellison, I., Kirsch-Darrow, L., Wint, D. P., Springer, U., Fernandez, H. H., Foote, K. D., Crucian, G., and Bowers, D. (2007). Deep brain stimulation and the role of the neuropsychologist. Clin. Neu-ropsychol. 21, 162-189.
73. Ory-Magne, F., Brefel-Courbon, C., Simonetta-Moreau, M., Fabre, N., Lotterie, J. A., Chaynes, P., Berry, I., Lazorthes, Y., and Rascol, O. (2007). Does ageing influence deep brain stimulation outcomes in Parkinson's disease? Mov. Disord. 22, 1457-1463.
74. Pahwa, R., Lyons, K. E., Wilkinson, S. B., Simpson, R. K., Ondo, W G., Tarsy, D., Norregaard, T., Hubble, J. P., Smith, D. A., Hauser, R. A., and Jankovic, J. (2006). Long-term evaluation of deep brain stimulation of the thalamus. J. Neurosurg. 104, 506-512.
75. Parkinson, J. (1817). An Essay on the Shaking Palsy. London: Sherwood, Neely, and Jones. Parsons, T. D., Rogers, S. A., Braaten, A. J., Woods, S. P., and Tröster, A. I. (2006). Cognitive sequelae of subthalamic nucleus deep brain stimulation in Parkinson's disease: a meta-analysis. Lancet Neurol. 5, 578-588.
76. Parsons, T. D., Rogers, S. A., Braaten, A. J., Woods, S. P., and Tröster, A. I. (2006). Cognitive sequelae of subthalamic nucleus deep brain stimulation in Parkinson's disease: a meta-analysis. Lancet Neurol. 5, 578-588.
77. Perozzo, P., Rizzone, M., Bergamasco, B., Castelli, L., Lanotte, M., Tavella, A., Torre, E., and Lopiano, L. (2001). Deep brain stimulation of the subthalamic nucleus in Parkinson's disease: comparison of pre-and postoperative neuropsychological evaluation. J. Neurol. Sci. 192, 9-15.
78. Pillon, B. (2002). Neuropsychological assessment for management of patients with deep brain stimulation. Mov. Disord. 17,S1 16-S122.
79. Pillon, B., Ardouin, C., Damier, P., Krack, P., Houeto, J., Klinger, H., Bonnet, A., Pollak, P., Benabid, A., and Agid, Y. (2000). Neuropsychological changes between "off" and "on" STN or GPi stimulation in Parkinson's disease. Neurology 55, 411-418.
80. Pillon, B., Dubois, B., Lhermitte, F., and Agid, Y. (1986). Heterogeneity of cognitive impairment in progressive supranuclear palsy, Parkinson's disease, and Alzheimer's disease. Neurology 36, 1179-1185.
81. Qiu, C., De Ronchi, D., and Fratiglioni, L. (2007). The epidemiology of the dementias: an update. Curr. Opin. Psychiatry 20, 380-385.
82. Rajput, A. H., Voll, A., Rajput, M. L., Robinson, C. A., and Rajput, A. (2009). Course in Parkinson disease subtypes: a 39-year clinicopatho-logic study. Neurology 73,206-212.
83. Rodriguez, R. L., Fernandez, H. H., Haq, I., and Okun, M. S. (2007). Pearls in patient selection for deep brain stimulation. Neurologist 13, 253-260.
84. Rodriguez-Oroz, M. C., Jahanshahi, M., Krack, P., Litvan, I., Macias, R., Bezard, E., and Obeso, J. A. (2009). Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms. LancetNeurol. 8,1128-1139.
85. Rothlind, J., Cockshott, R., Starr, P., and Marks, W (2007). Neuropsychological performance following staged bilateral pallidal or subthalamic nucleus deep brain stimulation for Parkinson's disease. J. Int. Neuropsychol. Soc. 13, 68-79.
86. Rouaud, T., Dondaine, T., Drapier, S., Haegelen, C., Lallement, F., Péron, J., Raoul, S., Sauleau, P., and Vérin, M. (2010). Pallidal stimulation in advanced Parkinson's patients with contraindications for subthalamic stimulation. Mov. Disord. 25,1839-1846.
87. Schapira, A. H. V. (2009). Neurobiol-ogy and treatment of Parkinson's disease. Trends Pharmacol. Sci. 30, 41-47.
88. Schermer, M. (2011). Ethical issues in deep brain stimulation. Front. Integr. Neurosci. 5:17. doi:10.3389/fnint.2011.00017
89. Schroeder, U., Kuehler, A., Lange, K. W., Haslinger, B., Tronnier, V. M., Krause, M., Pfister, R., Boecker, H., and Ceballos-Baumann, A. O. (2003). Subthalamic nucleus stimulation affects a frontotemporal network: a PET study. Ann. Neurol. 54, 445-450.
90. Schüpbach, W M. M., Chastan, N., Welter, M. L., Houeto, J. L., Mes-nage, V., Bonnet, A. M., Czernecki, V., Maltête, D., Hartmann, A., Mallet, L., Pidoux, B., Dormont, D., Navarro, S., Cornu, P., Mallet, A., and Agid, Y. (2005). Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up. J. Neurol. Neurosurg. Psychiatr. 76,1640-1644.
91. Smeding, H. M. M., Speelman, J. D., Huizenga, H. M., Schuurman, P. R., and Schmand, B. (2011). Predictors of cognitive and psychosocial outcome after STN DBS in Parkinson's disease. J. Neurol. Neurosurg. Psychiatr. 82, 754-760.
92. Smeding, H. M. M., Speelman, J. D., Koning-Haanstra, M., Schuurman, P. R., Nijssen, P., van Laar, T., and Schmand, B. (2006). Neuropsychological effects of bilateral STN stimulation in Parkinson disease: a controlled study. Neurology 66, 1830-1836.
93. Starkstein, S. E. (2012). Apathy in Parkinson's disease: diagnostic and etiological dilemmas. Mov. Disord. 27, 174-178.
94. Stuss, D. T., and Alexander, M. P. (2007). Is there a dysexecutive syndrome? Philos. Trans. R. Soc. Lond. B Biol. Sci. 362, 901-915.
95. Temel, Y., Blokland, A., Ackermans, L., Boon, P., van Kranen-Mastenbroek, V. H. J. M., Beuls, E. A. M., Spince-maille, G. H., and Visser-Vandewalle, V. (2006). Differential effects of subthalamic nucleus stimulation in advanced Parkinson disease on reaction time performance. Exp. Brain Res. 169, 389-399.
96. Temel, Y., Blokland, A., Steinbusch, H. W M., and Visser-Vandewalle, V. (2005). The functional role of the subthalamic nucleus in cognitive and limbic circuits. Prog. Neurobiol. 76, 393-413.
97. Tröster, A. I., Wilkinson, S. B., Fields, J. A., Miyawaki, K., and Koller, W. C. (1998). Chronic electrical stimulation of the left ventrointermediate (Vim) thalamic nucleus for the treatment of pharmacotherapy-resistant Parkinson's disease: a differential impact on access to semantic and episodic memory? Brain Cogn. 38, 125-149.
98. Utter,A.A.,andBasso,M.A. (2008).The basal ganglia: an overview of circuits and function. Neurosci. Biobehav. Rev. 32, 333-342.
99. Volkmann, J., Allert, N., Voges, J., Weiss, P., Freund, H. J., and Sturm, V. (2001). Safety and efficacy of pallidal or subthalamic nucleus stimulation in advanced PD. Neurology 56, 548-551.
100. Volkmann, J., Daniels, C., and Witt, K. (2010). Neuropsychiatric effects of subthalamic neurostimulation in Parkinson disease. Nat. Rev. Neurol. 6, 487-498.
101. Volkmann, J., Moro, E., and Pahwa, R. (2006). Basic algorithms for the programming of deep brain stimulation in Parkinson's disease. Mov. Disord. 21(Suppl. 1),S284-S289.
102. Voon, V., Krack, P., Lang, A. E., Lozano, A. M., Dujardin, K., Schüpbach, M., D'Ambrosia, J., Thobois, S., Tamma, F., Herzog, J., Speelman, J. D., Samanta, J., Kubu, C., Rossig-nol, H., Poon, Y. Y., Saint-Cyr, J. A., Ardouin, C., and Moro, E. (2008). A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease. Brain 131,2720-2728.
103. Voon, V., Kubu, C., Krack, P., Houeto, J.-L., and Tröster, A. I. (2006). Deep brain stimulation: neuropsychological and neuropsychiatric issues. Mov. Disord. 21(Suppl. 1), S305-S327.
104. Walter, B. L., and Vitek, J. L. (2004). Surgical treatment for Parkinson's disease. LancetNeurol. 3, 719-728.
105. Weaver, E M., Follett, K., Stern, M., Hur, K., Harris, C., Marks, W. J., Rothlind, J., Sagher, O., Reda, D., Moy, C. S., Pahwa, R., Burchiel, K., Hogarth, P., Lai, E. C., Duda, J. E., Holloway, K., Samii, A., Horn, S., Bronstein, J., Stoner, G., Heemskerk, J., Huang, G. D., and CSP 468 Study Group. (2009). Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA 301, 63-73.
106. Weintraub, D., Dietz, N., Duda, J. E., Wolk, D. A., Doshi, J., Xie, S. X., Davatzikos, C., Clark, C. M., and Siderowf,A. (2012). Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease. Brain 135, 170-180.
107. Williams, A., Gill, S., Varma, T., Jenk-inson, C., Quinn, N., Mitchell, R., Scott, R., Ives, N., Rick, C., Daniels, J., Patel, S., Wheatley, K., and PD SURG Collaborative Group. (2010). Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial. Lancet Neurol. 9,581-591.
108. Williams, A. E., Arzola, G. M., Strutt, A. M., Simpson, R., Jankovic, J., and York, M. K. (2011). Cognitive outcome and reliable change indices two years following bilateral subthal-amic nucleus deep brain stimulation. Parkinsonism Relat. Disord. 17, 321-327.
109. Williams-Gray, C. H., Evans, J. R., Goris, A., Foltynie, T., Ban, M., Robbins, T. W., Brayne, C., Kolachana, B. S., Weinberger, D. R., Sawcer, S. J., and Barker, R. A. (2009). The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort. Brain 132, 2958-2969.
110. Williams-Gray, C. H., Foltynie, T., Brayne, C. E. G., Robbins, T. W., and Barker, R. A. (2007). Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. Brain 130,1787-1798
111. Witt, K., Daniels, C., Reiff, J., Krack, P., Volkmann, J., Pinsker, M. O., Krause, M., Tronnier, V., Kloss, M., Schnitzler, A., Wojtecki, L., Bötzel, K., Danek, A., Hilker, R., Sturm, V., Kupsch, A., Karner, E., and Deuschl, G. (2008). Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study. LancetNeurol. 7, 605-614.
112. Witt, K., Pulkowski, U., Herzog, J., Lorenz, D., Hamel, W., Deuschl, G., and Krack, P. (2004). Deep brain stimulation of the subthalamic nucleus improves cognitive flexibility but impairs response inhibition in Parkinson disease. Arch. Neurol. 61,697-700.
113. Woods, S., Fields, J., Lyons, K., Koller, W., Wilkinson, S., Pahwa, R., and Tröster, A. (2001). Neuropsychological and quality of life changes following unilateral thalamic deep brain stimulation in Parkinson's disease: a one-year follow-up. Acta Neurochir. (Wien) 143, 1273-1278.
114. York, M. K., Dulay, M., Macias, A., Levin, H. S., Grossman, R., Simpson, R., and Jankovic, J. (2008). Cognitive declines following bilateral subthalamic nucleus deep brain stimulation for the treatment of Parkinson's disease. J. Neurol. Neurosurg. Psychiatr. 79, 789-795.
115. Zangaglia, R., Pacchetti, C., Pasotti, C., Mancini, F., Servello, D., Sin-foriani, E., Cristina, S., Sassi, M., and Nappi, G. (2009). Deep brain stimulation and cognitive functions in Parkinson's disease: a three-year controlled study. Mov. Disord. 24, 1621-1628.